MR Imaging Findings of Carcinoma Ex Pleomorphic Adenoma Related to Extracapsular Invasion and Prognosis

References

1. 1.↵
   1. Gnepp DR

   . Malignant mixed tumours of the salivary glands: a review. Pathol Annu 1993;28:279–328 pmid:8380049

   PubMedWeb of Science
2. 2.↵
   1. Olsen KD,
   2. Lewis JE

   . Carcinoma ex pleomorphic adenoma: a clinicopathologic review. Head Neck 2001;23:705–12 doi:10.1002/hed.1100 pmid:11505478

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Kashiwagi N,
   2. Murakami T,
   3. Chikugo T, et al

   . Carcinoma ex pleomorphic adenoma of the parotid gland. Acta Radiol 2012;53:303–06 doi:10.1258/ar.2011.110389 pmid:22287150

   CrossRefPubMed
4. 4.
   1. Kato H,
   2. Kanematsu M,
   3. Mizuta K, et al

   . Carcinoma ex pleomorphic adenoma of the parotid gland; radiopathologic correlation with MR imaging including diffusion-weighted imaging. AJNR Am J Neuroradiol 2008;29:865–67 doi:10.3174/ajnr.A0974 pmid:18272554

   Abstract/FREE Full Text
5. 5.↵
   1. Weiler C,
   2. Zengel P,
   3. van der Wal JE, et al

   . Carcinoma ex pleomorphic adenoma with special reference to the prognostic significance of histological progression: a clinicopathological investigation of 41 cases. Histopathology 2011;59:741–50 doi:10.1111/j.1365-2559.2011.03937.x pmid:22014054

   CrossRefPubMed
6. 6.↵
   1. El-Naggar AK,
   2. Chan JK,
   3. Grandis JR, et al

   . World Health Organization Classification of Tumours: Pathology and Genetics of Head and Neck Tumours. 4th ed. International Agency for Research on Cancer; 2017
7. 7.↵
   1. Guzzo M,
   2. Locati LD,
   3. Prott FJ, et al

   . Major and minor salivary gland tumors. Crit Rev Oncol Hematol 2010;74:134–48 doi:10.1016/j.critrevonc.2009.10.004 pmid:19939701

   CrossRefPubMed
8. 8.↵
   1. Webb AJ,
   2. Eveson JW

   . Pleomorphic adenomas of the major salivary glands: a study of the capsular form in relation to surgical management. Clin Otolaryngol Allied Sci 2001;26:134–42 doi:10.1046/j.1365-2273.2001.00440.x pmid:11309055

   CrossRefPubMed
9. 9.↵
   1. Klijanienko J,
   2. El-Naggar AK,
   3. Vielh P

   . Fine-needle sampling findings in 26 carcinoma ex pleomorphic adenomas: diagnostic pitfalls and clinical considerations. Diagn Cytopathol 1999;21:163–66 doi:10.1002/(SICI)1097-0339(199909)21:3<163::AID-DC3>3.0.CO;2-2 pmid:10450099

   CrossRefPubMed
10. 10.↵
    1. Wada T,
    2. Yokota H,
    3. Horikoshi T, et al

    . Diagnostic performance and inter-operator variability of apparent diffusion coefficient analysis for differentiating pleomorphic adenoma and carcinoma ex pleomorphic adenoma: comparing one-point measurement and whole-tumor measurement including radiomics approach. Jpn J Radiol 2020;38:207–14 doi:10.1007/s11604-019-00908-1 pmid:31820265

    CrossRefPubMed
11. 11.↵
    1. Landis JR,
    2. Koch GG

    . The measurement of observer agreement for categorical data. Biometrics 1977;33:159–74 doi:10.2307/2529310 pmid:843571

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Antony J,
    2. Gopalan V,
    3. Smith RA, et al

    . Carcinoma ex pleomorphic adenoma: a comprehensive review of clinical, pathological and molecular data. Head Neck Pathol 2012;6:1–9 doi:10.1007/s12105-011-0281-z pmid:21744105

    CrossRefPubMed
13. 13.↵
    1. Mărgăritescu C,
    2. Raica M,
    3. Simionescu C, et al

    . Tumoral stroma of salivary pleomorphic adenoma-histopathological, histochemical and immunohistochemical study. Rom J Morphol Embryol 2005;46:211–23 pmid:16444308

    PubMed
14. 14.↵
    1. de Sousa Lopes ML,
    2. Barroso KM,
    3. Henriques ÁC, et al

    . Pleomorphic adenomas of the salivary glands: retrospective multicentric study of 130 cases with emphasis on histopathological features. Eur Arch Otorhinolaryngol 2017;274:543–51 doi:10.1007/s00405-016-4253-5 pmid:27520570

    CrossRefPubMed
15. 15.↵
    1. Lewis JE,
    2. Olsen KD,
    3. Sebo TJ

    . Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases. Hum Pathol 2001;32:596–604 doi:10.1053/hupa.2001.25000 pmid:11431714

    CrossRefPubMedWeb of Science
16. 16.
    1. Auclair PL,
    2. Ellis GL

    . Atypical features in salivary gland mixed tumors: their relationship to malignant transformation. Mod Pathol 1996;9:652–67 [Database] pmid:8782203

    PubMedWeb of Science
17. 17.↵
    1. Ethunandan M,
    2. Witton R,
    3. Hoffman G, et al

    . Atypical features in pleomorphic adenoma–a clinico-pathologic study and implications for management. Int J Oral Maxillofac Surg 2006;35:608–12 doi:10.1016/j.ijom.2006.02.009 pmid:16540285

    CrossRefPubMed
18. 18.↵
    1. Mariano FV,
    2. Noronha AL,
    3. Gondak RO, et al

    . Carcinoma ex pleomorphic adenoma in a Brazilian population: clinico-pathological analysis of 38 cases. Int J Oral Maxillofac Surg 2013;42:685–92 doi:10.1016/j.ijom.2013.02.012 pmid:23561262

    CrossRefPubMed
19. 19.↵
    1. Zhao J,
    2. Wang J,
    3. Yu C, et al

    . Prognostic factors affecting the clinical outcome of carcinoma ex pleomorphic adenoma in the major salivary gland. World J Surg Onc 2013;11:180 doi:10.1186/1477-7819-11-180 pmid:23924064

    CrossRefPubMed
20. 20.
    1. Masahiro S,
    2. Takashi M,
    3. Satoshi S, et al

    . Carcinoma ex pleomorphic adenoma of the parotid gland: a multi-institutional retrospective analysis in the Northern Japan Head and Neck Cancer Society. Acta Otolaryngol 2016;136:1154–58 doi:10.1080/00016489.2016.1191671 pmid:27295405

    CrossRefPubMed
21. 21.↵
    1. Katabi N,
    2. Gomez D,
    3. Klimstra DS, et al

    . Prognostic factors of recurrence in salivary carcinoma ex pleomorphic adenoma, with emphasis on the carcinoma histologic subtype: a clinicopathologic study of 43 cases. Hum Pathol 2010;41:927–34 doi:10.1016/j.humpath.2009.12.011 pmid:20338616

    CrossRefPubMed